ID   WEE2_HUMAN              Reviewed;         567 AA.
AC   P0C1S8;
DT   05-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   28-JUL-2009, sequence version 2.
DT   12-OCT-2022, entry version 132.
DE   RecName: Full=Wee1-like protein kinase 2;
DE            EC=2.7.10.2;
DE   AltName: Full=Wee1-like protein kinase 1B;
DE   AltName: Full=Wee1B kinase;
GN   Name=WEE2; Synonyms=WEE1B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=11029659; DOI=10.1046/j.1365-2443.2000.00367.x;
RA   Nakanishi M., Ando H., Watanabe N., Kitamura K., Ito K., Okayama H.,
RA   Miyamoto T., Agui T., Sasaki M.;
RT   "Identification and characterization of human Wee1B, a new member of the
RT   Wee1 family of Cdk-inhibitory kinases.";
RL   Genes Cells 5:839-847(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [4]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-8; LYS-332; HIS-398; GLU-470 AND
RP   ASP-526.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [5]
RP   INVOLVEMENT IN OOMD5, VARIANT OOMD5 HIS-234, CHARACTERIZATION OF VARIANT
RP   OOMD5 HIS-234, FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND
RP   PHOSPHORYLATION.
RX   PubMed=29606300; DOI=10.1016/j.ajhg.2018.02.015;
RA   Sang Q., Li B., Kuang Y., Wang X., Zhang Z., Chen B., Wu L., Lyu Q., Fu Y.,
RA   Yan Z., Mao X., Xu Y., Mu J., Li Q., Jin L., He L., Wang L.;
RT   "Homozygous Mutations in WEE2 Cause Fertilization Failure and Female
RT   Infertility.";
RL   Am. J. Hum. Genet. 102:649-657(2018).
CC   -!- FUNCTION: Oocyte-specific protein tyrosine kinase that phosphorylates
CC       and inhibits CDK1/CDC2 and acts as a key regulator of meiosis during
CC       both prophase I and metaphase II (PubMed:29606300). Required to
CC       maintain meiotic arrest in oocytes during the germinal vesicle (GV)
CC       stage, a long period of quiescence at dictyate prophase I, by
CC       phosphorylating CDK1 at 'Tyr-15', leading to inhibit CDK1 activity and
CC       prevent meiotic reentry. Also required for metaphase II exit during egg
CC       activation by phosphorylating CDK1 at 'Tyr-15', to ensure exit from
CC       meiosis in oocytes and promote pronuclear formation (By similarity).
CC       {ECO:0000250|UniProtKB:Q66JT0, ECO:0000269|PubMed:29606300}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.2;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10027};
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11029659,
CC       ECO:0000269|PubMed:29606300}.
CC   -!- TISSUE SPECIFICITY: Expressed in oocytes (at protein level)
CC       (PubMed:29606300). May also be expressed in testis (PubMed:11029659).
CC       {ECO:0000269|PubMed:11029659, ECO:0000269|PubMed:29606300}.
CC   -!- PTM: Phosphorylated on serine residues (PubMed:29606300).
CC       Phosphorylation leads to increase its activity (By similarity).
CC       {ECO:0000250|UniProtKB:Q66JT0, ECO:0000269|PubMed:29606300}.
CC   -!- DISEASE: Oocyte maturation defect 5 (OOMD5) [MIM:617996]: An autosomal
CC       recessive infertility disorder characterized by oocyte inability to
CC       exit metaphase II, resulting in fertilization failure.
CC       {ECO:0000269|PubMed:29606300}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein
CC       kinase family. WEE1 subfamily. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK131218; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC004918; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS43660.1; -.
DR   RefSeq; NP_001099028.1; NM_001105558.1.
DR   PDB; 5VDK; X-ray; 2.70 A; A=202-492.
DR   PDBsum; 5VDK; -.
DR   AlphaFoldDB; P0C1S8; -.
DR   SMR; P0C1S8; -.
DR   BioGRID; 138978; 1.
DR   STRING; 9606.ENSP00000380675; -.
DR   BindingDB; P0C1S8; -.
DR   ChEMBL; CHEMBL5095; -.
DR   DrugCentral; P0C1S8; -.
DR   iPTMnet; P0C1S8; -.
DR   PhosphoSitePlus; P0C1S8; -.
DR   BioMuta; WEE2; -.
DR   DMDM; 254763343; -.
DR   MassIVE; P0C1S8; -.
DR   PaxDb; P0C1S8; -.
DR   PeptideAtlas; P0C1S8; -.
DR   PRIDE; P0C1S8; -.
DR   Antibodypedia; 32491; 111 antibodies from 23 providers.
DR   DNASU; 494551; -.
DR   Ensembl; ENST00000397541.6; ENSP00000380675.2; ENSG00000214102.7.
DR   Ensembl; ENST00000574659.5; ENSP00000459392.1; ENSG00000263042.5.
DR   GeneID; 494551; -.
DR   KEGG; hsa:494551; -.
DR   MANE-Select; ENST00000397541.6; ENSP00000380675.2; NM_001105558.1; NP_001099028.1.
DR   UCSC; uc003vwn.2; human.
DR   CTD; 494551; -.
DR   DisGeNET; 494551; -.
DR   GeneCards; WEE2; -.
DR   HGNC; HGNC:19684; WEE2.
DR   HPA; ENSG00000214102; Not detected.
DR   MalaCards; WEE2; -.
DR   MIM; 614084; gene.
DR   MIM; 617996; phenotype.
DR   neXtProt; NX_P0C1S8; -.
DR   OpenTargets; ENSG00000214102; -.
DR   Orphanet; 488191; Female infertility due to oocyte meiotic arrest.
DR   PharmGKB; PA134909633; -.
DR   VEuPathDB; HostDB:ENSG00000214102; -.
DR   eggNOG; KOG0601; Eukaryota.
DR   GeneTree; ENSGT00940000158803; -.
DR   HOGENOM; CLU_000288_25_1_1; -.
DR   InParanoid; P0C1S8; -.
DR   OMA; GAAWHHI; -.
DR   OrthoDB; 1063695at2759; -.
DR   PhylomeDB; P0C1S8; -.
DR   TreeFam; TF101088; -.
DR   PathwayCommons; P0C1S8; -.
DR   SignaLink; P0C1S8; -.
DR   BioGRID-ORCS; 494551; 11 hits in 1096 CRISPR screens.
DR   GenomeRNAi; 494551; -.
DR   Pharos; P0C1S8; Tchem.
DR   PRO; PR:P0C1S8; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; P0C1S8; protein.
DR   Bgee; ENSG00000214102; Expressed in ganglionic eminence and 82 other tissues.
DR   ExpressionAtlas; P0C1S8; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004672; F:protein kinase activity; IBA:GO_Central.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IBA:GO_Central.
DR   GO; GO:0007143; P:female meiotic nuclear division; ISS:UniProtKB.
DR   GO; GO:0035038; P:female pronucleus assembly; ISS:UniProtKB.
DR   GO; GO:0000278; P:mitotic cell cycle; IEA:InterPro.
DR   GO; GO:0045736; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; IEA:Ensembl.
DR   GO; GO:1900194; P:negative regulation of oocyte maturation; ISS:UniProtKB.
DR   GO; GO:0042327; P:positive regulation of phosphorylation; IEA:Ensembl.
DR   GO; GO:0080154; P:regulation of fertilization; IEA:Ensembl.
DR   GO; GO:0060631; P:regulation of meiosis I; ISS:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR017164; Wee1-like_protein_kinase.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF037281; Wee1-like_protein_kinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Coiled coil; Disease variant; Kinase; Magnesium;
KW   Meiosis; Metal-binding; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Transferase; Tyrosine-protein kinase.
FT   CHAIN           1..567
FT                   /note="Wee1-like protein kinase 2"
FT                   /id="PRO_0000248079"
FT   DOMAIN          212..486
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..117
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          514..567
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          494..519
FT                   /evidence="ECO:0000255"
FT   MOTIF           173..175
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250"
FT   MOTIF           315..329
FT                   /note="Nuclear export signal"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        1..49
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        66..80
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        100..117
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        339
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         218..226
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         241
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         344
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250"
FT   BINDING         380
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         76
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:A4PES0"
FT   VARIANT         8
FT                   /note="K -> T (in dbSNP:rs35672788)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041304"
FT   VARIANT         234
FT                   /note="D -> H (in OOMD5; decreased WEE2 phosphorylation at
FT                   serine residues; decreased CDK1/CDC2 phosphorylation at
FT                   'Y-15'; dbSNP:rs1554415096)"
FT                   /evidence="ECO:0000269|PubMed:29606300"
FT                   /id="VAR_080992"
FT   VARIANT         332
FT                   /note="N -> K (in a gastric adenocarcinoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041305"
FT   VARIANT         398
FT                   /note="R -> H (in an ovarian mucinous carcinoma sample;
FT                   somatic mutation; dbSNP:rs200610853)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041306"
FT   VARIANT         470
FT                   /note="D -> E (in dbSNP:rs55901099)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041307"
FT   VARIANT         526
FT                   /note="Y -> D (in dbSNP:rs35683659)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041308"
FT   CONFLICT        351
FT                   /note="M -> V (in Ref. 2; AK131218)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        529
FT                   /note="H -> Y (in Ref. 2; AK131218)"
FT                   /evidence="ECO:0000305"
FT   HELIX           207..211
FT                   /evidence="ECO:0007829|PDB:5VDK"
FT   STRAND          212..221
FT                   /evidence="ECO:0007829|PDB:5VDK"
FT   STRAND          224..231
FT                   /evidence="ECO:0007829|PDB:5VDK"
FT   TURN            232..234
FT                   /evidence="ECO:0007829|PDB:5VDK"
FT   STRAND          237..245
FT                   /evidence="ECO:0007829|PDB:5VDK"
FT   STRAND          251..253
FT                   /evidence="ECO:0007829|PDB:5VDK"
FT   HELIX           255..265
FT                   /evidence="ECO:0007829|PDB:5VDK"
FT   STRAND          275..281
FT                   /evidence="ECO:0007829|PDB:5VDK"
FT   STRAND          284..290
FT                   /evidence="ECO:0007829|PDB:5VDK"
FT   HELIX           297..306
FT                   /evidence="ECO:0007829|PDB:5VDK"
FT   HELIX           313..332
FT                   /evidence="ECO:0007829|PDB:5VDK"
FT   STRAND          344..348
FT                   /evidence="ECO:0007829|PDB:5VDK"
FT   STRAND          375..378
FT                   /evidence="ECO:0007829|PDB:5VDK"
FT   STRAND          385..389
FT                   /evidence="ECO:0007829|PDB:5VDK"
FT   HELIX           397..399
FT                   /evidence="ECO:0007829|PDB:5VDK"
FT   HELIX           402..405
FT                   /evidence="ECO:0007829|PDB:5VDK"
FT   TURN            410..412
FT                   /evidence="ECO:0007829|PDB:5VDK"
FT   HELIX           413..428
FT                   /evidence="ECO:0007829|PDB:5VDK"
FT   HELIX           437..443
FT                   /evidence="ECO:0007829|PDB:5VDK"
FT   TURN            444..446
FT                   /evidence="ECO:0007829|PDB:5VDK"
FT   HELIX           457..467
FT                   /evidence="ECO:0007829|PDB:5VDK"
FT   STRAND          469..471
FT                   /evidence="ECO:0007829|PDB:5VDK"
FT   HELIX           477..481
FT                   /evidence="ECO:0007829|PDB:5VDK"
SQ   SEQUENCE   567 AA;  62925 MW;  BC05DDFE96D87E3F CRC64;
     MDDKDIDKEL RQKLNFSYCE ETEIEGQKKV EESREASSQT PEKGEVQDSE AKGTPPWTPL
     SNVHELDTSS EKDKESPDQI LRTPVSHPLK CPETPAQPDS RSKLLPSDSP STPKTMLSRL
     VISPTGKLPS RGPKHLKLTP APLKDEMTSL ALVNINPFTP ESYKKLFLQS GGKRKIRGDL
     EEAGPEEGKG GLPAKRCVLR ETNMASRYEK EFLEVEKIGV GEFGTVYKCI KRLDGCVYAI
     KRSMKTFTEL SNENSALHEV YAHAVLGHHP HVVRYYSSWA EDDHMIIQNE YCNGGSLQAA
     ISENTKSGNH FEEPKLKDIL LQISLGLNYI HNSSMVHLDI KPSNIFICHK MQSESSGVIE
     EVENEADWFL SANVMYKIGD LGHATSINKP KVEEGDSRFL ANEILQEDYR HLPKADIFAL
     GLTIAVAAGA ESLPTNGAAW HHIRKGNFPD VPQELSESFS SLLKNMIQPD AEQRPSAAAL
     ARNTVLRPSL GKTEELQQQL NLEKFKTATL ERELREAQQA QSPQGYTHHG DTGVSGTHTG
     SRSTKRLVGG KSARSSSFTS GEREPLH
//
